Diabetes is a major worldwide health concern that currently affects millions of people worldwide and places great financial burden on society. Further troubling is that its growth rate continues to skyrocket. Regenerative Medical Solutions (RMS), a Chicago and Madison-based company, was formed to combat these alarming trends in diabetes through the use of its stem cell derived Islet-Like Clusters (ILC) for dual use in drug discovery applications (screening, toxicity, efficacy testing) and direct therapeutic use targeting diabetes. We know many families are affected by diabetes, including our own, which is a significant motivation in our quest to find a cure.